Becton Dickinson (BDX) came out with quarterly earnings of $3.17 per share, beating the Zacks Consensus Estimate of $2.96 per share. This compares to earnings of $2.86 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 7.09%. A quarter ago, it was expected that this medical device manufacturer would post earnings of $2.39 per share when it actually produced earnings of $2.68, delivering a surprise of 12.13%. Over the last four q ...

业绩总结 - 公司在2024年的总收入为504.5亿美元，同比增长4.6%[10] - 公司在2024年的净利润为92.1亿美元，同比增长11.5%[10] - 公司在2024年的每股稀释收益为3.17美元，同比增长12.6%[10]

Exhibit 99.1 1 Becton Drive Franklin Lakes, NJ 07417 www.bd.com Contacts: Investors: Adam Reiffe, Sr. Director, Investor Relations - 201-847-6927 Media: Troy Kirkpatrick, VP, Public Relations - 858-617-2361 BD Reports Second Quarter Fiscal 2024 Financial Results Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 • Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organic • Q2 GAAP and adjusted diluted EPS of $1.85 and $3.17 grew 20.9 ...

FRANKLIN LAKES, N.J., April 29, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time. The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion. About BD BD is one ...

Becton Dickinson and Company (BDX) , popularly known as BD, is scheduled to report second-quarter fiscal 2024 results on May 2, before market open. In the last reported quarter, the company’s earnings per share (EPS) of $2.68 surpassed the Zacks Consensus Estimate by 12.1%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on three occasions and matched once, delivering an earnings surprise of 4.6%, on average. Let’s check out the factors that have shaped BDX’s performa ...

Analysts on Wall Street project that Becton Dickinson (BDX) will announce quarterly earnings of $2.96 per share in its forthcoming report, representing an increase of 3.5% year over year. Revenues are projected to reach $5.03 billion, increasing 4.3% from the same quarter last year. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. Prior to a company's ...

Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that target ...

产品创新 - BDX公司在过去几个月推出了一系列产品，为未来几个季度的增长奠定了良好基础[1] - BDX公司最近发布了新的细胞分选器BD FACSDiscover S8 Cell Sorters，展示了其在产品创新方面的积极态度[7] 战略合作 - BDX公司与Camtech Health和Techcyte等公司达成战略合作协议，推动了宫颈癌筛查和识别技术的进步[5][6]

FRANKLIN LAKES, N.J., April 9, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. Best Employers: Excellence in Health and Well-being Award Logo BD also garnered honors for "Excellence in Global Health & Well-b ...

Becton, Dickinson and Company (BDX) , popularly known as BD, recently announced the global commercial release of new cell sorters, the new BD FACSDiscover S8 Cell Sorters. This will likely enable researchers in a broader range of fields (including cell biology, cancer research and immunology) to provide insights that were previously invisible in traditional flow cytometry experiments. The new BD FACSDiscover S8 Cell Sorters feature BD CellView Image Technology and BD SpectralFX Technology. This, according t ...